Primary Recipient

MOLECULAR EXPRESS INC

Amount

$197,977.00

Award Date

5/11/2010

Administering Agency

Health and Human Services, Department of / National Institutes of Health

CDFA Number

93.701

CDFA Program Title

Trans-NIH Recovery Act Research Support

Description

The Company has been developing a new approach to immunization for herpes simplex virus type 2 (HSV2) infections that combines a unilamellar liposome carrier with a recombinant protein system that is capable of being engineered to express selected antigen